Breast Cancer Research Centre-WA

Nedlands, Western Australia 6009

0 studies enrolling now · 7 studies all time

What they study most

Advanced Breast Cancer, Breast Cancer, Cancer, Endometrial Cancer, HER2 Positive Solid Tumors, Locally Advanced or Unresectable Metastatic Breast Cancer, Metastatic Breast Cancer, Metastatic Colorectal Cancer, Metastatic Triple Negative Breast Cancer, Stage IV Breast Cancer

Studies at this site

• A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer — Running, not enrolling
• PALbociclib CoLlaborative Adjuvant Study — Running, not enrolling
• Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer — Running, not enrolling
• Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy — Running, not enrolling
• Study of Talimogene Laherparepvec With Atezolizumab for Triple Negative Breast Cancer and Colorectal Cancer With Liver Metastases — Completed
• A Study of Neoadjuvant Nivolumab + Palbociclib + Anastrozole in Post-Menopausal Women and Men With Primary Breast Cancer — Completed
• A Study of SBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Solid Tumors — Status unconfirmed